Singh Rishabh K, Zhao Yan, Elze Tobias, Fingert John, Gordon Mae, Kass Michael A, Luo Yuyang, Pasquale Louis R, Scheetz Todd, Segrè Ayellet V, Wiggs Janey L, Zebardast Nazlee
Department of Ophthalmology, Columbia University Medical Center, New York, NY.
Schepens Eye Research Institute, Harvard Medical School, Boston, MA.
medRxiv. 2023 Aug 16:2023.08.15.23294141. doi: 10.1101/2023.08.15.23294141.
Primary open-angle glaucoma (POAG) is a highly heritable disease with 127 identified risk loci. Polygenic risks score (PRS) offers a measure of aggregate genetic burden. In this study, we assess whether PRS improves risk stratification in patients with ocular hypertension.
A post-hoc analysis of the Ocular Hypertension Treatment Study (OHTS) data.
SETTING PARTICIPANTS AND/OR CONTROLS: 1636 participants were followed from 1994 to 2020 across 22 sites. The PRS was computed for 1009 OHTS participants using summary statistics from largest cross-ancestry POAG metanalysis with weights trained using 8,813,496 variants from 488,395 participants in the UK Biobank.
Survival regression analysis, with endpoint as development of POAG, predicted disease onset from PRS incorporating baseline covariates.
Outcome measures were hazard ratios for POAG onset. Concordance index and time-dependent AUC were used to compare the predictive performance of multivariable Cox-Proportional Hazards models.
Mean PRS was significantly higher for POAG-converters (0.24 ± 0.95) than for non-converters (-0.12 ± 1.00) (p < 0.01). POAG risk increased 1.36% with each higher PRS decile, with conversion ranging from 9.5% in the lowest PRS decile to 21.8% in the highest decile. Comparison of low- and high-risk PRS tertiles showed a 1.8-fold increase in 20-year POAG risk for participants of European and African ancestries (p<0.01). In the subgroup randomized to delayed treatment, each increase in PRS decile was associated with a 0.52-year decrease in age at diagnosis, (p=0.05). No significant linear relationship between PRS and age at POAG diagnosis was present in the early treatment group. Prediction models significantly improved with the addition of PRS as a covariate (C-index = 0.77) compared to OHTS baseline model (C-index=0.75) (p<0.01). One standard deviation higher PRS conferred a mean hazard ratio of 1.25 (CI=[1.13, 1.44]) for POAG onset.
Higher PRS is associated with increased risk for, and earlier development of POAG in patients with ocular hypertension. Early treatment may mitigate the risk from high genetic burden, delaying clinically detectable disease by up to 5.2 years. The inclusion of a PRS improves the prediction of POAG onset.
原发性开角型青光眼(POAG)是一种高度可遗传的疾病,已确定有127个风险位点。多基因风险评分(PRS)提供了一种衡量总体遗传负担的方法。在本研究中,我们评估PRS是否能改善高眼压症患者的风险分层。
对高眼压症治疗研究(OHTS)数据进行事后分析。
1994年至2020年期间,对22个地点的1636名参与者进行了随访。使用来自最大的跨祖先POAG荟萃分析的汇总统计数据,为1009名OHTS参与者计算了PRS,权重采用来自英国生物银行488,395名参与者的8,813,496个变体进行训练。
方法、干预措施或检测:生存回归分析,以POAG的发生为终点,根据纳入基线协变量的PRS预测疾病发作。
结局指标为POAG发作的风险比。一致性指数和时间依赖性AUC用于比较多变量Cox比例风险模型的预测性能。
POAG转化者的平均PRS(0.24±0.95)显著高于未转化者(-0.12±1.00)(p<0.01)。PRS每升高一个十分位数,POAG风险增加1.36%,转化率从最低PRS十分位数的9.5%到最高十分位数的21.8%不等。对低风险和高风险PRS三分位数的比较显示,欧洲和非洲血统参与者的20年POAG风险增加了1.8倍(p<0.01)。在随机接受延迟治疗的亚组中,PRS每升高一个十分位数,诊断时的年龄就会降低0.52岁(p=0.05)。在早期治疗组中,PRS与POAG诊断时的年龄之间没有显著的线性关系。与OHTS基线模型(C指数=0.75)相比,添加PRS作为协变量后,预测模型显著改善(C指数=0.77)(p<0.01)。PRS每升高一个标准差,POAG发作的平均风险比为1.25(CI=[1.13, 1.44])。
较高的PRS与高眼压症患者POAG风险增加及发病较早相关。早期治疗可能减轻高遗传负担带来的风险,将临床可检测疾病的发生延迟多达5.2年。纳入PRS可改善POAG发作的预测。